Experts’ Perspective on Gestational Diabetes Mellitus

Dear Dr. Renukaprasad A R, Gestational diabetes mellitus (GDM) is the most prevalent issue during pregnancy. GDM increases the risk of maternal and neonatal complications during pregnancy.1 Join us on 26th July 2023 at 4:00 PM IST to learn more about GDM and its management. We look forward to seeing you there! Don't forget to share the event link with your fellow HCPs and help them improve their practice! Save Your Seat Reference McIntyre HD et al., Nat Rev Dis Primers. 2019 Jul 11;5(1):47. Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

India: Minimum Three Years of Service Mandatory to Qualify as an In-service NEET PG Candidate, and More

Dear Dr. Renukaprasad A R, Top Stories of the Day: India: Three Years of Service Mandatory for In-service Status of NEET PG Candidates Malaysia: Over 200 Doctors Reject Contract Positions in Sarawak Phase 2 Trial Demonstrates Efficacy of Peresolimab for Treating Rheumatoid Arthritis India: IMA Urges to Appoint Only Medical Postgraduates as Teachers in Medical Colleges Healthcare headlines that matter, brought to you every day by Docplexus Health Minute! Watch News Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Can Early Metformin Reduce the Risk of Long-COVID?

Can Early Metformin Reduce the Risk of Long-COVID? Metformin has shown activity against the SARS-CoV-2 in human lung tissue ex vivo at a physiologically relevant dose. Read the findings from a randomized phase 3 trial that explored the effect of metformin on the risk of long COVID development when given early to COVID-19 outpatients. Know the Findings mRNA Vaccines May Neutralize SARS-CoV-2 Virus in Nasal Mucosa Intramuscular mRNA vaccines against the SARS-CoV-2 exponentially increase the systemic production of virus-specific IgG and IgA antibodies. However, its effect on antibody production or neutralizing virus within the nasal mucosa is unknown. To address this knowledge gap, researchers analyzed immune responses in 29 healthy participants before and after mRNA vaccination from their serum and nasal epithelial lining fluid samples. Read to know more. See What's New Ruling Out Preeclampsia in a Pregnant COVID-19 Patient  A 39-year-old G5P1 pregnant woman (26 weeks of gestation) presented with worsening dyspnea and cough. The symptoms had started five days ago. A multidisciplinary team of experts in general medicine, infectious disease, and maternal-fetal medicine discussed the possibility of preeclampsia in the patient. They suggested a test to rule out preeclampsia. Which one do you think it was? A. Liver function test B. Serum creatinine test C. Placental growth factor test D. Platelet count test Click to Answer How Can You Biochemically Differentiate Between COVID-19 and MIS-C? Multisystem inflammatory syndrome in children (MIS-C) is associated with COVID-19. The current diagnosis of MIS-C relies primarily on clinical symptoms and therefore it is often misdiagnosed. To effectively differentiate between COVID-19 and MIS-C, researchers analyzed blood samples of 237 pediatric patients with COVID-19 or MIS-C to reveal the distinct nucleic acid biomarkers involved in each condition. Read to know what they found. Read More Docplexus: One of the world's largest online communities of Doctors Pune - 411025, INDIA info@docplexus.co.in | +91-98500 36954 You received this mail because you opted-in to receive promotional mails from Docplexus. Change email preference.